Rosenblum Mark J 4
4 · Salarius Pharmaceuticals, Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2024-02-20+22,500→ 22,500 totalExercise: $0.57From: 2025-02-20Exp: 2034-02-19→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]25% of the options are vested on February 20, 2025, and 1/36 of the remaining options vest on each monthly anniversary thereafter for 36 months.